Levima Advanced Materials Corporation

XSEC:003022 Stock Report

Market Cap: CN¥20.7b

Levima Advanced Materials Past Earnings Performance

Past criteria checks 0/6

Levima Advanced Materials's earnings have been declining at an average annual rate of -12.8%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 3.2% per year. Levima Advanced Materials's return on equity is 2.8%, and it has net margins of 3.2%.

Key information

-12.8%

Earnings growth rate

-15.7%

EPS growth rate

Chemicals Industry Growth12.1%
Revenue growth rate3.2%
Return on equity2.8%
Net Margin3.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Levima Advanced Materials makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSEC:003022 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 246,808220340338
30 Jun 246,884261374341
31 Mar 246,689350375323
31 Dec 236,778446351309
30 Sep 236,676493340307
30 Jun 237,426735333321
31 Mar 238,177906319342
01 Jan 238,157866333331
30 Sep 228,3321,046320342
30 Jun 227,6931,006312323
31 Mar 227,333928338290
01 Jan 227,5811,091320273
30 Sep 217,6361,040448240
30 Jun 217,148952369222
31 Mar 216,561812345197
31 Dec 205,931641304163
30 Sep 205,501533273116
31 Dec 195,67453231325
31 Dec 185,79522926011
31 Dec 174,6595523312
31 Dec 164,0171883228

Quality Earnings: 003022 has a large one-off gain of CN¥375.2M impacting its last 12 months of financial results to 30th September, 2024.

Growing Profit Margin: 003022's current net profit margins (3.2%) are lower than last year (7.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 003022's earnings have declined by 12.8% per year over the past 5 years.

Accelerating Growth: 003022's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 003022 had negative earnings growth (-55.3%) over the past year, making it difficult to compare to the Chemicals industry average (-5.3%).


Return on Equity

High ROE: 003022's Return on Equity (2.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies